Economic Evaluations of Advanced Practice Nursing in the Management of Non‐Communicable Diseases: A Systematic Review
Abstract
ABSTRACT Aim To evaluate the economic value of advanced practice nursing in the management of non‐communicable diseases. Design Systematic review without meta‐analysis. Methods Six databases were searched. Title/abstract and full‐text screening, and data extraction were performed independently by two reviewers, with disagreements resolved by a third reviewer. Risk of bias was assessed using RoB 2.0 and ROBINS‐I; economic reporting quality was assessed using CHEERS 2022. Certainty of evidence was rated using GRADE. Data Sources PubMed, Scopus, Web of Science, CINAHL, Cochrane Library and EconLit searched from 2012 to March 2026. Results Twenty studies published between 2012 and 2025 were included, most reporting favourable economic outcomes to advanced practice nursing, although results varied by economic perspective and time horizon. Conclusion Advanced practice nursing is a clinically effective and economically efficient response to the growing burden of non‐communicable diseases, despite heterogeneous results and limited evidence from low‐ and middle‐income countries. Implications for the Profession and/or Patient Care Advanced practice nursing offers an efficient response to chronic disease management, supporting its wider implementation, particularly in under‐resourced settings. Impact This review addresses the lack of up‐to‐date evidence on the economic efficiency of advanced practice nursing in chronic disease management. Efficiency was generally favourable but context‐sensitive, with implications for nursing workforce planning and health policy. Reporting Method PRISMA 2020, supplemented by Synthesis Without Meta‐analysis guidance. Patient or Public Contribution No patient or public contribution. Trial Registration PROSPERO: CRD420261336116